PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24826N0520Thyroid CANCER molecular TESTS — Interpace Diagnostics Corp

Interpace Diagnostics Corp holds $288K across 2 federal awards, concentrated at Department of Veterans Affairs (VA). Recompete timing centers on the May 27, 2027 PoP end — agencies typically plan 12–18 months ahead.

248-Network Contract Office 8 (36C248)

Awarding office

Interpace Diagnostics Corp

Recipient

May 27, 2027

PoP end

$288K

Obligated

$288K

Potential

621511

NAICS

6640

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Interpace Diagnostics Corp — $90

Contract facts

Federal

Contract number36C24826N0520

Also listed as36C248-26-N-0520

Also listed as36C24826D0032-36C24826N0520

Agency248-Network Contract Office 8 (36C248)

Awarding office248-Network Contract Office 8 (36C248)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentInterpace Diagnostics Corp

CAGE5C4D8

UEIF3JTMG615829

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSC6640

Parent IDIQ / IDV36C24826D0032

Place of performanceORLANDO FL

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startMay 28, 2026

PoP end (current)May 27, 2027

Obligated$288K

Current value$288K

Potential value$288K

THYROID CANCER MOLECULAR TESTS is a federal award for 248-Network Contract Office 8 (36C248) held by Interpace Diagnostics Corp. Estimated value $288K ($288K obligated). Current period of performance ends May 27, 2027. Place of performance: ORLANDO FL.

Recompete timing

Public

● Expiring in 263 days

Current PoP ends May 27, 2027 (263 days remaining). Agencies typically plan 12–18 months ahead — at 8.6 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Interpace Diagnostics Corp — $288K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$288K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24826N0520?

36C24826N0520 (Thyroid CANCER molecular TESTS) is a 248-Network Contract Office 8 (36C248) award with a potential value of $288K, currently held by Interpace Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C248-26-N-0520?

36C248-26-N-0520 is the dashed form of PIID 36C24826N0520 (Thyroid CANCER molecular TESTS), held by Interpace Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24826N0520?

248-Network Contract Office 8 (36C248) awarded 36C24826N0520 to Interpace Diagnostics Corp (potential $288K).

Who is the incumbent on 36C24826N0520?

Interpace Diagnostics Corp is the incumbent with $288K across 2 related awards in SCOUT’s public footprint. The current period of performance ends May 27, 2027.

When does Interpace Diagnostics Corp’s 36C24826N0520 come up for recompete?

SCOUT tracks a period-of-performance end of May 27, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C24826N0520 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 29, 2026